Detalles de la búsqueda
1.
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).
Lancet
; 374(9683): 39-47, 2009 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-19515413
2.
Liraglutide treatment is associated with a low frequency and magnitude of antibody formation with no apparent impact on glycemic response or increased frequency of adverse events: results from the Liraglutide Effect and Action in Diabetes (LEAD) trials.
J Clin Endocrinol Metab
; 96(6): 1695-702, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21450987
Resultados
1 -
2
de 2
1
Próxima >
>>